🔗 Permalink

Inventor profile of:

Markus Münz

City:

Munich

Country:

Germany

Published Applications:

Last publication date:

2025-10-30

Top Assignees for applications by Markus Münz

The entities that hold a legal rights for patent applications filed by inventor Münz Markus:

AMGEN RESEARCH (MUNICH) GMBH 6 Munich, Germany
Amgen Inc. 2 Thousand Oaks, CA United States

Recent patent applications by Münz Markus

Markus Münz from Munich, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-30

US20250333537A1

Chemistry; metallurgy

PSMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#2 | 2025-10-30

US20250333535A1

Chemistry; metallurgy

BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION

#3 | 2023-06-22

US20230192884A1

Chemistry; metallurgy

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

#4 | 2021-03-11

US20210070878A1

Chemistry; metallurgy

PSMA and CD3 Bispecific T Cell Engaging Antibody Constructs

#5 | 2020-02-13

US20200048357A1

Chemistry; metallurgy

BCMA and CD3 bispecific T cell engaging antibody constructs

#6 | 2019-06-06

US20190169295A1

Chemistry; metallurgy

LONG LIFE POLYPEPTIDE BINDING MOLECULES

#7 | 2017-12-07

US20170349668A1

Chemistry; metallurgy

Optimized cross-species specific bispecific single chain antibody contructs

#8 | 2017-09-28

US20170275373A1

Chemistry; metallurgy

BISPECIFIC SINGLE CHAIN ANTIBODY CONSTRUCT WITH ENHANCED TISSUE DISTRIBUTION

#9 | 2017-08-03

US20170218079A1

Chemistry; metallurgy

PSMA and CD3 bispecific T cell engaging antibody constructs

#10 | 2017-08-03

US20170218078A1

Chemistry; metallurgy

Bispecific T cell engaging antibody constructs

#11 | 2017-08-03

US20170218077A1

Chemistry; metallurgy

BCMA and CD3 bispecific T cell engaging antibody constructs

InventorID:

1945629 ⎘